The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels*
Abstract
KATP channels are a newly defined class of potassium channels based on the physical association of an ABC protein, the sulfonylurea receptor, and a K+ inward rectifier subunit. The beta-cell KATP channel is composed of SUR1, the high-affinity sulfonylurea receptor with multiple TMDs and two NBFs, and KIR6.2, a weak inward rectifier, in a 1:1 stoichiometry. The pore of the channel is formed by KIR6.2 in a tetrameric arrangement; the overall stoichiometry of active channels is (SUR1/KIR6.2)4. The two subunits form a tightly integrated whole. KIR6.2 can be expressed in the plasma membrane either by deletion of an ER retention signal at its C-terminal end or by high-level expression to overwhelm the retention mechanism. The single-channel conductance of the homomeric KIR6.2 channels is equivalent to SUR/KIR6.2 channels, but they differ in all other respects, including bursting behavior, pharmacological properties, sensitivity to ATP and ADP, and trafficking to the plasma membrane. Coexpression with SUR restores the normal channel properties. The key role KATP channel play in the regulation of insulin secretion in response to changes in glucose metabolism is underscored by the finding that a recessive form of persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is caused by mutations in KATP channel subunits that result in the loss of channel activity. KATP channels set the resting membrane potential of beta-cells, and their loss results in a constitutive depolarization that allows voltage-gated Ca2+ channels to open spontaneously, increasing the cytosolic Ca2+ levels enough to trigger continuous release of insulin. The loss of KATP channels, in effect, uncouples the electrical activity of beta-cells from their metabolic activity. PHHI mutations have been informative on the function of SUR1 and regulation of KATP channels by adenine nucleotides. The results indicate that SUR1 is important in sensing nucleotide changes, as implied by its sequence similarity to other ABC proteins, in addition to being the drug sensor. An unexpected finding is that the inhibitory action of ATP appears to be through a site located on KIR6.2, whose affinity for ATP is modified by SUR1. A PHHI mutation, G1479R, in the second NBF of SUR1 forms active KATP channels that respond normally to ATP, but fail to activate with MgADP. The result implies that ATP tonically inhibits KATP channels, but that the ADP level in a fasting beta-cell antagonizes this inhibition. Decreases in the ADP level as glucose is metabolized result in KATP channel closure. Although KATP channels are the target for sulfonylureas used in the treatment of NIDDM, the available data suggest that the identified KATP channel mutations do not play a major role in diabetes. Understanding how KATP channels fit into the overall scheme of glucose homeostasis, on the other hand, promises insight into diabetes and other disorders of glucose metabolism, while understanding the structure and regulation of these channels offers potential for development of novel compounds to regulate cellular electrical activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cloning and functional expression of a rat heart KATP channel
Ashford, M. L. J., Bond, C. T., Blair, T. A., & Adelmair, J. P. (1994) · Nature · doi:10.1038/370456a0 · Cited by 181
RetractedPositional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312 · cited 1×
“The greatest sequence similarities are in the NBFs that have the Walker A (-GlyXXGlyXGlyLysSer/ Thr-, where X is any amino acid) and B (-YYYYAsp-, where Y is a hydrophobic amino acid) consensus motifs (181) and a conserved -LeuSerGlyGlyGln- sequence in the segment linking the two Walker motifs.”
BackgroundBIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · cited 4×
“This topology resembled the model originally put forward for MRP1 (175).”
BackgroundMethodInfluentialRASMOL: biomolecular graphics for all
Sayle, R. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89080-5 · Cited by 2,575
ATP-regulated K+ channels in cardiac muscle
Noma, A. (1983) · Nature · doi:10.1038/305147a0 · Cited by 2,328
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327
Cited by
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098
Hypothalamic KATP channels control hepatic glucose production
Pocai, A., Lam, T. K. T., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J., Aguilar-Bryan, L., & Rossetti, L. (2005) · Nature · doi:10.1038/nature03439 · Cited by 645
Self-citationGenetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216112 · Cited by 536
Miki, T., Liss, B., Minami, K., Shiuchi, T., Saraya, A., Kashima, Y., Horiuchi, M., Ashcroft, F., Minokoshi, Y., Roeper, J., et al. (2001) · Nature Neuroscience · doi:10.1038/87455 · Cited by 512
Sulfonylurea Stimulation of Insulin Secretion
Proks, P., Reimann, F., Green, N., Gribble, F., & Ashcroft, F. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s368 · Cited by 510
Physiological and pathophysiological roles of ATP-sensitive K+ channels
Seino, S., & Miki, T. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(02)00053-6 · Cited by 505
The selfish brain: Competition for energy resources
Peters, A., Schweiger, U., Pellerin, L., Hubold, C., Oltmanns, K. M., Conrad, M., Schultes, B., Born, J., & Fehm, H. L. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.002 · Cited by 489
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481
Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis
Lam, T. K. T., Pocai, A., Gutierrez-Juarez, R., Obici, S., Bryan, J., Aguilar-Bryan, L., Schwartz, G. J., & Rossetti, L. (2005) · Nature Medicine · doi:10.1038/nm1201 · Cited by 432
Self-citationGlucose Sensing in Pancreatic β-Cells
Schuit, F. C., Huypens, P., Heimberg, H., & Pipeleers, D. G. (2001) · Diabetes · doi:10.2337/diabetes.50.1.1 · Cited by 405
Seghers, V., Nakazaki, M., DeMayo, F., Aguilar-Bryan, L., & Bryan, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9270 · Cited by 365
Self-citationGlucose-sensing mechanisms in pancreatic β-cells
MacDonald, P. E., Joseph, J. W., & Rorsman, P. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1762 · Cited by 352
Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1
Miki, T., Suzuki, M., Shibasaki, T., Uemura, H., Sato, T., Yamaguchi, K., Koseki, H., Iwanaga, T., Nakaya, H., & Seino, S. (2002) · Nature Medicine · doi:10.1038/nm0502-466 · Cited by 347
Genotype and Phenotype Correlations in 417 Children With Congenital Hyperinsulinism
Snider, K. E., Becker, S., Boyajian, L., Shyng, S.-L., MacMullen, C., Hughes, N., Ganapathy, K., Bhatti, T., Stanley, C. A., & Ganguly, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2169 · Cited by 333
Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis
RUTTER, G. A., da SILVA XAVIER, G., & LECLERC, I. (2003) · Biochemical Journal · doi:10.1042/bj20030048 · Cited by 328
MicroRNA-124a Regulates Foxa2 Expression and Intracellular Signaling in Pancreatic β-Cell Lines*
Baroukh, N., Ravier, M. A., Loder, M. K., Hill, E. V., Bounacer, A., Scharfmann, R., Rutter, G. A., & Van Obberghen, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611841200 · Cited by 326
Kang, L., Routh, V. H., Kuzhikandathil, E. V., Gaspers, L. D., & Levin, B. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.549 · Cited by 311
Florez, J. C., Burtt, N., de Bakker, P. I. W., Almgren, P., Tuomi, T., Holmkvist, J., Gaudet, D., Hudson, T. J., Schaffner, S. F., Daly, M. J., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1360 · Cited by 309
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
Rendell, M. (2004) · Drugs · doi:10.2165/00003495-200464120-00006 · Cited by 308
Practical management of hyperinsulinism in infancy
Aynsley-Green, A., Hussain, K., Hall, J., Saudubray, J. M., Nihoul-Fékété, C., De Lonlay-Debeney, P., Brunelle, F., Otonkoski, T., Thornton, P., & Lindley, K. J. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.82.2.f98 · Cited by 298
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 293
Nielsen, E.-M. D., Hansen, L., Carstensen, B., Echwald, S. M., Drivsholm, T., Glümer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2003) · Diabetes · doi:10.2337/diabetes.52.2.573 · Cited by 288
Sulphonylurea action revisited: the post-cloning era
Gribble, F. M., & Reimann, F. (2003) · Diabetologia · doi:10.1007/s00125-003-1143-3 · Cited by 284
“The first pathogenic mutations in SUR1 to be discovered were in subjects with congenital hyperinsulinism (CHI or persistent hyperinsulinaemic hypoglycaemia of infancy, PHHI) [56, 69].”
InfluentialBensellam, M., Laybutt, D. R., & Jonas, J.-C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 284
Bauer, B. E., Wolfger, H., & Kuchler, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00160-1 · Cited by 279
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1
Huopio, H., Reimann, F., Ashfield, R., Komulainen, J., Lenko, H.-L., Rahier, J., Vauhkonen, I., Kere, J., Laakso, M., Ashcroft, F., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9804 · Cited by 276
Otonkoski, T., Näntö-Salonen, K., Seppänen, M., Veijola, R., Huopio, H., Hussain, K., Tapanainen, P., Eskola, O., Parkkola, R., Ekström, K., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1128 · Cited by 269
Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic α-Cells
Ravier, M. A., & Rutter, G. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1789 · Cited by 264
Emerging Roles of the Membrane Potential: Action Beyond the Action Potential
Abdul Kadir, L., Stacey, M., & Barrett-Jolley, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01661 · Cited by 264
Glucose‐stimulated insulin secretion: A newer perspective
Komatsu, M., Takei, M., Ishii, H., & Sato, Y. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12094 · Cited by 256
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle, M. E., & Egan, J. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.7 · Cited by 256
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism
Kapoor, R. R., Flanagan, S. E., Arya, V. B., Shield, J. P., Ellard, S., & Hussain, K. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0673 · Cited by 243
HANLEY, P., & DAUT, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.002 · Cited by 218
Varadi, A., Ainscow, E. K., Allan, V. J., & Rutter, G. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.00083 · Cited by 156
“In contrast to whole islets (Curry t al., 1968) both INS-1 (Asfari et al., 1992) and MIN6 (Ainscowet al., 2000) β-cells display essentially monophasic Journal of Cell Science 115 (21) insulin release in which the early (KATP-channel-dependent) phase of release (Asfari et al., 1992) is followed by sustained release of…”
BackgroundInfluentialElectrophysiology of Islet Cells
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-90-481-3271-3_7 · Cited by 152
Leung, Y. M., Kwan, E. P., Ng, B., Kang, Y., & Gaisano, H. Y. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0010 · Cited by 106
Varadi, A., Tsuboi, T., Johnson-Cadwell, L. I., Allan, V. J., & Rutter, G. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.208 · Cited by 86
Schwanstecher, C., Neugebauer, B., Schulz, M., & Schwanstecher, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s363 · Cited by 62
Muñoz, A., Hu, M., Hussain, K., Bryan, J., Aguilar-Bryan, L., & Rajan, A. S. (2005) · Endocrinology · doi:10.1210/en.2005-0637 · Cited by 58
Self-citationGlucose Acutely Decreases pH of Secretory Granules in Mouse Pancreatic Islets
Stiernet, P., Guiot, Y., Gilon, P., & Henquin, J.-C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513224200 · Cited by 51
Jiao, J., Garg, V., Yang, B., Elton, T. S., & Hu, K. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110817 · Cited by 51
Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor
Shiota, C., Rocheleau, J. V., Shiota, M., Piston, D. W., & Magnuson, M. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00102.2005 · Cited by 44
Metadata
- Authors
- Aguilar-Bryan, L., & Bryan, J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-04-01
- Volume
- 20
- Issue
- 2
- Pages
- 101-135
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1975863794
- Cited by
- 698
- References
- 310
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.